(Q43181191)

15 November 2017

title

Antagonism at serotonin 5-HT(2A) receptors modulates functional activity of frontohippocampal circuit (English)

1 reference

15 November 2017

0 references

Alessandro Gozzi

1

0 references

author name string

Valerio Crestan

2

1 reference

15 November 2017

Giuliano Turrini

3

1 reference

15 November 2017

Marcel Clemens

4

1 reference

15 November 2017

Angelo Bifone

5

1 reference

15 November 2017

publication date

29 January 2010

1 reference

15 November 2017

number of pages

14

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

15 November 2017

volume

209

1 reference

15 November 2017

issue

1

1 reference

15 November 2017

page(s)

37-50

1 reference

https://scigraph.springernature.com/pub.10.1007/s00213-009-1772-4

15 November 2017

exact match

0 references

cites work

Comparison of ketamine-induced thought disorder in healthy volunteers and thought disorder in schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS00213-009-1772-4

Phencyclidine-induced psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-009-1772-4

Transient and long-lasting actions of 5-HT on rat dentate gyrus neurones in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-009-1772-4

Intra-prefrontal 8-OH-DPAT and M100907 improve visuospatial attention and decrease impulsivity on the five-choice serial reaction time task in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-009-1772-4

A three-dimensional statistical analysis for CBF activation studies in human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-009-1772-4

Neuroleptic drug interactions with norepinephrine alpha receptor binding sites in rat brain

21 January 2018

1 reference

12 December 2020

The metabotropic glutamate 2/3 receptor agonists LY354740 and LY379268 selectively attenuate phencyclidine versus d-amphetamine motor behaviors in rats

1 reference

12 December 2020

Reversal of phencyclidine-induced prepulse inhibition deficits by clozapine in monkeys

1 reference

12 December 2020

Hypermetabolic pattern in frontal cortex and other brain regions in unmedicated schizophrenia patients. Results from a FDG-PET study

1 reference

12 December 2020

Antagonism by 8-OH-DPAT, but not ritanserin, of catalepsy induced by SCH 23390 in the rat

1 reference

12 December 2020

Serotonin research: contributions to understanding psychoses

1 reference

12 December 2020

NMDA receptor antagonists ketamine and PCP have direct effects on the dopamine D(2) and serotonin 5-HT(2)receptors-implications for models of schizophrenia

1 reference

12 December 2020

Dopaminergic behaviour stereospecific promoted by the D1 agonist R-SK & F 38393 and selectively blocked by the D1 antagonist SCH 23390

1 reference

12 December 2020

NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development

1 reference

12 December 2020

Effects of SCH-23390 on dopamine D1 receptor occupancy and locomotion produced by intraaccumbens cocaine infusion.

1 reference

12 December 2020

Functional MRI using intravascular contrast agents: detrending of the relative cerebrovascular (rCBV) time course

1 reference

12 December 2020

DOI-Induced activation of the cortex: dependence on 5-HT2A heteroceptors on thalamocortical glutamatergic neurons

1 reference

12 December 2020

M100907, a selective 5-HT(2A) receptor antagonist, attenuates phencyclidine-induced Fos expression in discrete regions of rat brain

1 reference

12 December 2020

Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex.

1 reference

12 December 2020

Amphetamine-induced glutamate efflux in the rat ventral tegmental area is prevented by MK-801, SCH 23390, and ibotenic acid lesions of the prefrontal cortex.

1 reference

12 December 2020

Chemistry of the mind: neurochemical modulation of prefrontal cortical function

1 reference

12 December 2020

Validation of a rat in vivo [(3)H]M100907 binding assay to determine a translatable measure of 5-HT(2A) receptor occupancy

1 reference

12 December 2020

Wavelet-based cluster analysis: data-driven grouping of voxel time courses with application to perfusion-weighted and pharmacological MRI of the rat brain.

1 reference

12 December 2020

Quantification of SCH 39166, a novel selective D1 dopamine receptor antagonist, in rat brain and blood

1 reference

12 December 2020

5-Hydroxytryptamine2 receptor facilitates GABAergic neurotransmission in rat hippocampus.

1 reference

12 December 2020

Pharmacological stimulation of NMDA receptors via co-agonist site suppresses fMRI response to phencyclidine in the rat.

1 reference

12 December 2020

Investigation of the effects of lamotrigine and clozapine in improving reversal-learning impairments induced by acute phencyclidine and D-amphetamine in the rat.

1 reference

12 December 2020

Serotonin receptors in the human brain. II. Characterization and autoradiographic localization of 5-HT1C and 5-HT2 recognition sites.

1 reference

12 December 2020

NMDA receptors and schizophrenia.

1 reference

12 December 2020

NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons

1 reference

12 December 2020

Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics.

1 reference

12 December 2020

SB-243213; a selective 5-HT2C receptor inverse agonist with improved anxiolytic profile: lack of tolerance and withdrawal anxiety

1 reference

12 December 2020

Atypical antipsychotics block the excitatory effects of serotonin in septohippocampal neurons in the rat.

1 reference

12 December 2020

Immediate and delayed effects of risperidone on cerebral metabolism in neuroleptic naïve schizophrenic patients: correlations with symptom change

1 reference

12 December 2020

1 reference

12 December 2020

A functional neuroanatomy of hallucinations in schizophrenia

1 reference

12 December 2020

Serotonergic/glutamatergic interactions: the effects of mGlu 2/3 receptor ligands in rats trained with LSD and PCP as discriminative stimuli

1 reference

12 December 2020

A stereotaxic MRI template set for the rat brain with tissue class distribution maps and co-registered anatomical atlas: application to pharmacological MRI.

1 reference

12 December 2020

Linking nucleus accumbens dopamine and blood oxygenation.

1 reference

12 December 2020

Atypical antipsychotics: mechanism of action.

1 reference

12 December 2020

CPP, a selective N-methyl-D-aspartate (NMDA)-type receptor antagonist: characterization in vitro and in vivo

1 reference

12 December 2020

The selective 5-HT2A receptor antagonist, MDL 100,907, increases dopamine efflux in the prefrontal cortex of the rat

1 reference

12 December 2020

Electrophysiological, biochemical and behavioral evidence for 5-HT2 and 5-HT3 mediated control of dopaminergic function

1 reference

12 December 2020

Investigation of the CNS penetration of a potent 5-HT2a receptor antagonist (MDL 100,907) and an active metabolite (MDL 105,725) using in vivo microdialysis sampling in the rat.

1 reference

12 December 2020

Differential effects of the 5-HT(2A) receptor antagonist M100907 and the 5-HT(2C) receptor antagonist SB242084 on cocaine-induced locomotor activity, cocaine self-administration and cocaine-induced reinstatement of responding

1 reference

12 December 2020

A drug discrimination analysis of the actions of novel serotonin1A receptor ligands in the rat using the 5-HT1A receptor agonist, 8-hydroxy-2-(di-n-propylamino)tetralin.

1 reference

12 December 2020

Cerebrovascular dynamics of autoregulation and hypoperfusion. An MRI study of CBF and changes in total and microvascular cerebral blood volume during hemorrhagic hypotension

1 reference

12 December 2020

NNC-112, NNC-687 and NNC-756, new selective and highly potent dopamine D1 receptor antagonists

1 reference

12 December 2020

Activation of mesolimbic dopamine function by phencyclidine is enhanced by 5-HT(2C/2B) receptor antagonists: neurochemical and behavioural studies

1 reference

12 December 2020

M100907, a serotonin 5-HT2A receptor antagonist and putative antipsychotic, blocks dizocilpine-induced prepulse inhibition deficits in Sprague-Dawley and Wistar rats

1 reference

12 December 2020

Brain hemodynamic changes mediated by dopamine receptors: Role of the cerebral microvasculature in dopamine-mediated neurovascular coupling

1 reference

12 December 2020

Effects of subanesthetic doses of ketamine on regional cerebral blood flow, oxygen consumption, and blood volume in humans

1 reference

12 December 2020

Anesthetics inhibit high-affinity states of dopamine D2 and other G-linked receptors

1 reference

12 December 2020

Differential effects of antipsychotic and glutamatergic agents on the phMRI response to phencyclidine

1 reference

12 December 2020

Brain metabolism in patients with schizophrenia before and after acute neuroleptic administration

1 reference

12 December 2020

Glutamate and the neural basis of the subjective effects of ketamine: a pharmaco-magnetic resonance imaging study

1 reference

12 December 2020

Placebo-controlled evaluation of four novel compounds for the treatment of schizophrenia and schizoaffective disorder

1 reference

12 December 2020

Serotonin receptors: their key role in drugs to treat schizophrenia

1 reference

12 December 2020

Interactive effects of subanesthetic ketamine and haloperidol in healthy humans.

1 reference

12 December 2020

Excitatory actions of serotonin on GABAergic neurons of the medial septum and diagonal band of Broca.

1 reference

12 December 2020

Dynamic functional imaging of relative cerebral blood volume during rat forepaw stimulation.

1 reference

12 December 2020

Dissociable contribution of 5-HT1A and 5-HT2A receptors in the medial prefrontal cortex to different aspects of executive control such as impulsivity and compulsive perseveration in rats

1 reference

12 December 2020

Immediate effects of risperidone on cortico-striato-thalamic loops and the hippocampus

1 reference

12 December 2020

Preclinical characterization of the potential of the putative atypical antipsychotic MDL 100,907 as a potent 5-HT2A antagonist with a favorable CNS safety profile

1 reference

12 December 2020

Regulation of Septo-Hippocampal Activity by 5-Hydroxytryptamine2C Receptors

1 reference

12 December 2020

Mapping the central effects of ketamine in the rat using pharmacological MRI.

1 reference

12 December 2020

The 5-HT2A receptor antagonist M100,907 attenuates motor and 'impulsive-type' behaviours produced by NMDA receptor antagonism

1 reference

12 December 2020

Effects of the serotonin 5-HT2A and 5-HT2C receptor ligands on the discriminative stimulus effects of nicotine in rats.

1 reference

12 December 2020

Serotonin model of schizophrenia: emerging role of glutamate mechanisms

1 reference

12 December 2020

Serotonin induces excitatory postsynaptic potentials in apical dendrites of neocortical pyramidal cells.

1 reference

12 December 2020

Probing the human hippocampus using rCBF: contrasts in schizophrenia

1 reference

12 December 2020

Group II metabotropic glutamate receptor modulation of DOI-induced c-fos mRNA and excitatory responses in the cerebral cortex

1 reference

12 December 2020

Alterations in local cerebral glucose utilization induced by phencyclidine.

1 reference

12 December 2020

A multimodality investigation of cerebral hemodynamics and autoregulation in pharmacological MRI.

1 reference

12 December 2020

Efflux of dopamine from the synaptic cleft in the nucleus accumbens of the rat brain

1 reference

12 December 2020

Supranormal stimulation of D1 dopamine receptors in the rodent prefrontal cortex impairs spatial working memory performance.

1 reference

12 December 2020

The serotonin 5-HT2A receptors antagonist M100907 prevents impairment in attentional performance by NMDA receptor blockade in the rat prefrontal cortex

1 reference

12 December 2020

Effects of NMDA receptor antagonists: implications for the pathophysiology of schizophrenia

1 reference

12 December 2020

Cellular and subcellular distribution of the serotonin 5-HT2A receptor in the central nervous system of adult rat

1 reference

12 December 2020

Characterization of the 5-HT2 receptor antagonist MDL 100907 as a putative atypical antipsychotic: behavioral, electrophysiological and neurochemical studies.

1 reference

12 December 2020

The hallucinogen 1-[2,5-dimethoxy-4-iodophenyl]-2-aminopropane (DOI) increases cortical extracellular glutamate levels in rats

1 reference

12 December 2020

Prefrontal dysfunction in young acute neuroleptic-naive schizophrenic patients: A resting and activation SPECT study

1 reference

12 December 2020

WAY-163909 [(7bR,10aR)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole]: A novel 5-hydroxytryptamine 2C receptor-selective agonist with preclinical antipsychotic-like activity.

1 reference

12 December 2020

Effect of the 5-HT2 antagonist mianserin on cognitive dysfunction in chronic schizophrenia patients: an add-on, double-blind placebo-controlled study

1 reference

12 December 2020

Serotonin(2C) receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: a combined dialysis and electrophysiological analysis in the rat

1 reference

12 December 2020

5-HT2 receptor antagonism reduces hyperactivity induced by amphetamine, cocaine, and MK-801 but not D1 agonist C-APB

1 reference

12 December 2020

RARE imaging: A fast imaging method for clinical MR

1 reference

12 December 2020

Human pharmacological MRI.

1 reference

12 December 2020

Control of serotonergic function in medial prefrontal cortex by serotonin-2A receptors through a glutamate-dependent mechanism.

1 reference

12 December 2020

Reversal of subchronic PCP-induced deficits in attentional set shifting in rats by sertindole and a 5-HT6 receptor antagonist: comparison among antipsychotics.

1 reference

12 December 2020

The 5-HT receptor antagonist M100,907 prevents extracellular glutamate rising in response to NMDA receptor blockade in the mPFC.

1 reference

12 December 2020

Effect of clozapine, haloperidol, or M100907 on phencyclidine-activated glutamate efflux in the prefrontal cortex

1 reference

12 December 2020

Regional brain function, emotion and disorders of emotion

1 reference

12 December 2020

Do NMDA receptor antagonist models of schizophrenia predict the clinical efficacy of antipsychotic drugs?

1 reference

12 December 2020

Effects of antipsychotic drugs on extracellular dopamine levels in rat medial prefrontal cortex and nucleus accumbens.

1 reference

12 December 2020

Region-specific effects of nicotine on brain activity: a pharmacological MRI study in the drug-naïve rat.

1 reference

12 December 2020

Comparative efficacy of antipsychotics in the treatment of schizophrenia: a critical assessment

1 reference

12 December 2020

Relationship between dopaminergic and serotonergic neuronal activity in the frontal cortex and the action of typical and atypical antipsychotic drugs

1 reference

12 December 2020

Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values

1 reference

12 December 2020

Chemical identity of 5-HT2A receptor immunoreactive neurons of the rat septal complex and dorsal hippocampus

1 reference

12 December 2020

A.E. Bennett Research Award. Reversal of phencyclidine-induced effects by glycine and glycine transport inhibitors.

1 reference

12 December 2020

Neuroimaging studies of the hippocampus in schizophrenia

1 reference

12 December 2020

Pharmacological modulation of functional connectivity: the correlation structure underlying the phMRI response to d-amphetamine modified by selective dopamine D3 receptor antagonist SB277011A.

1 reference

12 December 2020

Serotonin receptors represent highly favorable molecular targets for cognitive enhancement in schizophrenia and other disorders

1 reference

12 December 2020

Study-level wavelet cluster analysis and data-driven signal models in pharmacological MRI.

1 reference

12 December 2020

Drug-anaesthetic interaction in phMRI: the case of the psychotomimetic agent phencyclidine

1 reference

12 December 2020

Pre-clinical pharmacology of atypical antipsychotic drugs: a selective review

1 reference

12 December 2020

Circuit analysis of NMDAR hypofunction in the hippocampus, in vitro, and psychosis of schizophrenia

1 reference

12 December 2020

The effect of rate of drug administration on the extent and time course of phencyclidine distribution in rat brain, testis, and serum

1 reference

12 December 2020

10.1007/S00213-009-1772-4

Identifiers

DOI

1 reference

Dimensions Publication ID

15 November 2017

1002632600

0 references

1 reference